Building for the Future: Enabling Dual Payload ADCs Without Off-Target Toxicity

3:30 pm - Tuesday 13th October 2026

  • Exploring how the CysTyr platform enables novel structures and payloads design for next-generation ADCs
  • Leveraging precise DAR control to drive optimal ADC efficacy 
  • Beyond classical ADCs: Enabling next generation conjugate therapies

Speakers:

Co-Founder & Chief Executive Officer
CatenaBio